Daily non-political popular news in brief.

CSHL scientists successfully target tumor microenvironment to stop cancer growth

Cold Spring Harbor Laboratory (CSHL) researchers led by Daniel Nolan and Assistant Professor Vivek Mittal have found that bone marrow (BM) derived endothelial progenitor cells (EPCs) play a critical role in the early stages of tumor progression and that eliminating EPCs stops cancer growth.

Read more »

Keywords: cshl, scientists, successfully, target, tumor, microenvironment, stop, cancer, growth, scientist

« Previous | Next »

Similar news on "CSHL scientists successfully target tumor microenvironment to stop cancer growth":

1. Scientists take next step in understanding potential target for Ovarian cancer treatment
   07-16-2007 · EurekAlert!
   A traffic cop protein in the cell may have an even more important role: transporting a messenger protein that tells components in the nucleus to stop cell growth. Scientists are studying the normal function of a protein called 'km23', the traffic cop protein, because the team previously found altered forms of the protein in 42 percent of tumor tissue samples taken from women with Ovarian cancer. The discovery of this additional role may lead to diagnostic tools and earlier treatments for Ovarian cancer.
   Similar news · Read more »
   
2. Jefferson scientists find tumor suppressor gene protects against pre-cancerous development
   11-01-2006 · EurekAlert!
   Cell biologists have provided further evidence that a gene thought to play a role in suppressing tumors actually protects against the development of pre-cancerous cell growth as well. The researchers say that the gene, caveolin-1, which they found in two major types of breast cells, could be a potential target for future drugs aimed at preventing breast cancer. The work also suggests a potentially important role of the tumor "microenvironment" in the cancerous process.
   Similar news · Read more »
   
3. Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment
   09-23-2007 · EurekAlert!
   Italian scientists will announce on Monday (Sept. 24) that they have found a new and promising target for anti-tumor therapy in cancer. Professor Saverio Alberti, from the CESI, University of Chieti Foundation, Chieti, will tell the European Cancer Conference that he and his team have found a widespread mechanism for the stimulation of tumor growth in man, and that this is leading to the development of novel diagnostic and therapeutic procedures.
   Similar news · Read more »
   
4. Immune response to cancer stem cells may dictate cancer's course
   03-26-2007 · EurekAlert!
   Mounting evidence shows that a tumor's growth and spread may depend on "cancer stem cells," which comprise only a very small subset of the tumor. A new study by Rockefeller University scientists shows that immunity to cancer stem cells may help protect people with a precancerous condition from developing the full-blown disease, and that these cells could be an important target for cancer vaccines.
   Similar news · Read more »
   
5. Immune system can drive cancers into dormant state
   11-18-2007 · EurekAlert!
   A multinational team of researchers has shown for the first time that the immune system can stop the growth of a cancerous tumor without actually killing it. Scientists have been working for years to use the immune system to eradicate cancers. The new findings prove an alternate to this approach exists: When the cancer can't be killed with immune attacks, it may be possible to find ways to use the immune system to contain it.
   Similar news · Read more »
   
6. Reversing cancer cells to normal cells
   04-29-2007 · EurekAlert!
   A Northwestern University scientist describes new research that used an innovative experimental approach to provide unique insights into how scientists can change human metastatic melanoma cells back to normal-like skin cells -- by exposing the tumor cells to the embryonic microenvironment of human embryonic stem cells, the zebra fish and the chick embryo.
   Similar news · Read more »
   
7. Human C-reactive protein regulates myeloma tumor cell growth and survival
   09-10-2007 · EurekAlert!
   Scientists report that a protein best known as a common marker of inflammation plays a key role in the progression of human cancer. The research, published by Cell Press in the September issue of the journal Cancer Cell, implicates C-reactive protein (CRP) as a potential target for cancer treatment.
   Similar news · Read more »
   
8. Study offers innovative profile of enzyme that aids tumor growth
   10-20-2006 · EurekAlert!
   Using an innovative profiling strategy, scientists at the Scripps Research Institute have characterized an enzyme that is "highly elevated" in aggressive human tumor cells. When the enzyme, KIAA1363, was inactivated, it impaired tumor growth and migration in both ovarian and breast cancer cells, suggesting that inhibitors of this enzyme may prove valuable in the treatment of multiple types of cancer.
   Similar news · Read more »
   
9. Novel regulation of the common tumor suppressor PTEN
   01-11-2007 · EurekAlert!
   PTEN is one of the most commonly mutated tumor suppressor genes. It is an antagonist for many cellular growth, proliferation and survival processes. When mutated or deleted, it causes cancers of the prostate, breast, colon and brain. Researchers led by scientists at Memorial Sloan-Kettering Cancer Center have now identified fundamentally novel regulatory mechanisms of PTEN function. The findings from two related studies are published in the Jan. 12 issue of Cell.
   Similar news · Read more »
   
10. Study shows big power of small RNAs, not just proteins, in halting cancer
    06-06-2007 · EurekAlert!
    CSHL researchers have identified a family of micro RNAs that enable a known tumor suppressor network to fight cancer growth.
    Similar news · Read more »